Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for Cancer Treatment - Pharmacology and Mechanisms - Review

Sep 24, 2026

Uploaded by Stanley

Cancer, as the leading cause of death worldwide, creates a pressing need for effective tumor treatments. Natural products remain a key source for drug discovery, and Withaferin A (WA)—an active phytocompound from Withania somnifera—shows notable anti-tumor activity. This review summarizes WA’s pharmacological profile as a drug candidate, drawing on extensive literature evidence. WA suppresses tumor growth across many cancers in vitro and in vivo and modulates multiple pathways, including apoptosis, autophagy, ferroptosis, metastasis, EMT, and angiogenesis.

LanguageEnglish

CategoryHealthcare

FormatPDF

Pages21

Reading Time53 min

AccessFree to download

Abstract

Introduction

Cancer burden and need for new therapies

Natural products and dietary compounds in anti-cancer discovery

Withania somnifera and Withaferin A overview

Pharmacology, mechanisms, and potential targets

Drug Design, Development and Therapy Dovepress open access to scientific and medical research Open Access Full Text Article REVIEW Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for Cancer Treatment - Pharmacology and Mechanisms Zhichao Xing 1 , *, Anping Su 1 , *, Li Mi 1 , Yujie Zhang 1 , Ting He 1 , Yuxuan Qiu 2 , Tao Wei 1 , Zhihui Li 1 , Jingqiang Zhu 1 , Wenshuang Wu 1 1Division of Thyroid Surgery, Department of General Surgery and Laboratory of Thyroid and Parathyroid Disease, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, People’s Republic of China; 2Department of Ultrasound, West China Hospital, Sichuan University, Chengdu, People’s Republic of China *These authors contributed equally to this work Correspondence: Jingqiang Zhu; Wenshuang Wu, Division of Thyroid Surgery, Department of General Surgery and Laboratory of Thyroid and Parathyroid Disease, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, People’s Republic of China, Email [zhujingqiang@scu.edu.cn](zhujingqiang@scu.edu.cn); [wenshuang_wu@163.com](wenshuang_wu@163.com) | Abstract: Cancer, as the leading cause of death worldwide, poses a serious threat to human health, making the development of effective tumor treatments a significant challenge. Natural products continue to serve as crucial resources for drug discovery. Among them, Withaferin A (WA), the most active phytocompound extracted from the renowned dietary supplement Withania somnifera (L.) Dunal, exhibits remarkable anti-tumor efficacy. In this manuscript, we aim to comprehensively summarize the pharmacological characteristics of WA as a potential anti-tumor drug candidate, with the objective of contributing to its further development and the discovery of prospective drugs. Through an extensive review of literature from PubMed, Science Direct, and Web of Science, we have gathered substantial evidence showcasing WA’s significant anti-tumor effects against a wide range of cancers in both in vitro and in vivo studies. Mechanistically, WA exerts its anti-tumor influence by inducing cell cycle arrest, apoptosis, autophagy, and ferroptosis. Additionally, it inhibits cell proliferation, cancer stem cells, tumor metastasis, and also suppresses epithelial-mesenchymal transition (EMT) and angiogenesis. Several studies have identified direct target proteins of WA, such as vimentin, Hsp90, annexin II and mFAM72A, while BCR-ABL, Mortalin (mtHsp70), Nrf2, and c-MYB are potential targets of WA. Notwithstanding its remarkable anti-tumor efficacy, there are some limitations associated with WA, including potential toxicity and poor oral bioavailability, which need to be addressed when considering it as an anti-tumor candidate agent. Nevertheless, I given its promising anti-tumor attributes, WA remains an encouraging candidate for future drug development. Unveiling the exact target and comprehensive mechanism of WA’s action represents a crucial research direction to pursue in the future.
Keywords: Withaferin A, Withania somnifera, dietary supplement, anti-cancer activity, pharmacological mechanism, direct target | | --- | | Introduction
Cancer poses a severe threat to human health and has emerged as a leading cause of death in many countries worldwide, particularly those experiencing rapid population growth and aging. According to the 2020 global cancer statistics, there were 19.3 million new cases and almost 10.0 million cancer-related deaths. It is projected that the number of cancer cases will rise to 28.4 million by the year 2040.1 Consequently, there is an urgent need for novel anti-cancer drugs and treatment approaches.
Natural products have long been vital in drug discovery due to their unique biocompatibility, novel structural backbones, and diverse pharmacological activities. Many anti-cancer agents are either natu

FAQs

What is Withaferin A (WA) and why is it considered for cancer therapy?

Withaferin A is an active phytocompound extracted from Withania somnifera. It shows significant anti-tumor efficacy and is discussed as a promising therapeutic drug candidate for cancer treatment.

How does WA exert anti-tumor effects according to the review?

WA influences cancer through multiple mechanisms, including inducing cell cycle arrest, apoptosis, autophagy, and ferroptosis. It also suppresses proliferation, cancer stem cells, metastasis, EMT, and angiogenesis.

What limitations may affect WA’s development as an anti-tumor agent?

Despite strong anti-tumor activity, WA is associated with potential toxicity and poor oral bioavailability, which need to be addressed for future development.

Sep 24, 2026

Uploaded by Stanley